C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
12/2006
12/20/2006	EP1733740A1 Therapeutic agent for auris interna disorder containing il-6 antagonist as active ingredient
12/20/2006	EP1733737A1 Axon regeneration promoter
12/20/2006	EP1733736A2 Method of producing recombinant antibodies against tumours
12/20/2006	EP1733230A1 Assays for amphetamine and methamphetamine using stereospecific reagents
12/20/2006	EP1733057A2 L-sign polymorphisms and methods involving use of same
12/20/2006	EP1733041A2 Anti-myostatin antibodies
12/20/2006	EP1733037A2 Process for producing polypeptides
12/20/2006	EP1733034A2 Methods and constructs for expressing polypeptide multimers in eukaryotic cells using alternative splicing
12/20/2006	EP1732952A2 Gold-binding protein and use thereof
12/20/2006	EP1732951A2 Monoclonal antibodies with specificity for fetal erythroid cells
12/20/2006	EP1732950A2 Antibodies to erythropoietin receptor and uses thereof
12/20/2006	EP1732949A2 Methods for treating bone cancer pain by administering a nerve growth factor antagonist
12/20/2006	EP1732948A2 Therapeutic synergy of anti-cancer compounds
12/20/2006	EP1732947A2 Growth factor binding constructs materials and methods
12/20/2006	EP1732880A1 Assays for amphetamine and methamphetamine
12/20/2006	EP1732650A1 Composition and method for cancer treatment
12/20/2006	EP1732648A2 Treatment of diseases
12/20/2006	EP1732608A2 Folate conjugates and complexes
12/20/2006	EP1732603A1 Cytotoxicity mediation of cells evidencing surface expression of cd63
12/20/2006	EP1732602A1 Cytotoxicity mediation of cells evidencing surface expression of mcsp
12/20/2006	EP1732601A1 Cytotoxicity mediation of cells evidencing surface expression of cd44
12/20/2006	EP1732600A2 Uses of anti-ctla-4 antibodies
12/20/2006	EP1732599A1 Use of emmprin antagonists for the treatment of diseases associated with excessive angiogenesis
12/20/2006	EP1732596A2 Therapeutic use of rm1 antigen
12/20/2006	EP1732588A2 Modulation of nkg2d
12/20/2006	EP1732382A2 Sfec, a sperm flagellar energy carrier protein
12/20/2006	EP1687421A4 A process for producing exogenous protein in the milk of trangenic mammals and a process for purifying proteins therefrom
12/20/2006	EP1578783A4 Target recognizing binding agents
12/20/2006	EP1565492B1 Identification of tsh receptor autoantibodies using affinity-purified antibodies
12/20/2006	EP1563298A4 Methods of isolation of active compounds and activated targets
12/20/2006	EP1379556B1 Anti pilyrosporum ovale igy and its uses
12/20/2006	EP1261719B1 27411, a human phosphatidyl-glycerolphosphate (pgp) synthase
12/20/2006	EP1194164B1 Prion protein peptides and uses thereof
12/20/2006	EP1147123B1 Novel odorant receptors in drosophila
12/20/2006	EP1135477B1 Humanized monoclonal integrin antibodies
12/20/2006	EP0972032B1 Peptides for the treatment of systemic lupus erythematosus
12/20/2006	EP0942983B1 Streptococcus pneumoniae antigens and vaccines
12/20/2006	CN1882685A A process for producing exogenous protein in the milk of trangenic mammals and a process for purifying proteins therefrom
12/20/2006	CN1882611A Antibody variable region of a monoclonal antibody against human tumor necrosis factor alpha and a gene encoding the same
12/20/2006	CN1882610A High-yield method for the production of human antibodies blocking the biological activity of a human cytokine
12/20/2006	CN1882609A Altering a B cell pathology using self-derived antigens in conjunction with specific-binding cytoreductive agent
12/20/2006	CN1882605A Improved expression systems using Sec-system secretion
12/20/2006	CN1882602A The moduilation of hyaluronan synthesis and degradation in the treatment of disease
12/20/2006	CN1880447A Process for preparing high-flux monoclonal antibody
12/20/2006	CN1880446A Antibody complexes
12/20/2006	CN1880335A Monoclonal antibody for resisting human myeloblast differentiation marker gene and its uses
12/20/2006	CN1879877A Tumour-specific animal proteins
12/20/2006	CN1290864C Ant CD20 chimeric antibody
12/20/2006	CN1290861C New type human bone marrow stroma cell source 1 type phosphatase inhibition factor, its coded sequence and use
12/20/2006	CN1290580C Chick lecithal immune globulin products against rolavirus
12/20/2006	CA2549086A1 Chimeric polypeptides and their therapeutic applications against a flaviviridae infection
12/20/2006	CA2508266A1 Chimeric polypeptides and their therapeutic application against a flaviviridae infection
12/19/2006	USRE39433 Therapeutic agents as cytokine antagonists and agonists
12/19/2006	US7151172 virion infectivity factor (vif) proteins; use in vaccine against the HIV-1 virus
12/19/2006	US7151169 For therapy of fibrosis, immune responses and tumor progression, asthma
12/19/2006	US7151166 Immunoglobulin which binds alpha helix cytokine for detection of wound healing and cell proliferative agents
12/19/2006	US7151165 Antibodies immunospecific for a novel human G-protein coupled receptor family
12/19/2006	US7151164 Genetic engineered, chimera and human monoclonal antibodies that bind to lymphocytes CD antigens, used for diagnosis and prohylaxis of cancer and autoimmune diseases
12/19/2006	US7151160 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/19/2006	US7151159 Amino acid sequences for therapeutic and prophylactic use against diseases due to clostridium difficile toxins
12/19/2006	US7151086 Bone morphogenetic protein (BMP)-17 and BMP-18 compositions
12/19/2006	US7151082 Administering an effective amount of an antagonist or inhibitor of high mobility group 1 protein (HMG1) for therapy of condition characterized by activation of the inflammatory cytokine cascade
12/19/2006	US7150983 Modified proteolytic enzyme for treatment of osteoarthritis
12/19/2006	US7150979 Nucleotide sequences coding polypeptide for use as diagnostic tools genetic engineering
12/19/2006	US7150872 Chemical modification of single chain polypeptides by means of covalent attachment of strands of polyethylene glycol to single chain polypeptide binding molecules that have three dimensional folding and binding ability
12/19/2006	US7150871 Treatment of acute lung injury, fibrosis and metastasis with antagonists of αvβ6
12/19/2006	US7150869 Gene therapy; cytokine complex; anticancer agent
12/19/2006	CA2145064C Improvements in or relating to immune response modification
12/14/2006	WO2006133398A2 In vitro activated donor t-cells to promote transplant engraftment
12/14/2006	WO2006133286A2 Treatment of tnf antagonist-resistant inflammatory disorders and related methods
12/14/2006	WO2006133164A2 Anti-trkb monoclonal antibodies and uses thereof
12/14/2006	WO2006133148A2 Method of producing antibodies with modified fucosylation level
12/14/2006	WO2006132907A2 Methods of treating, diagnosing or detecting cancer using an ephb3 modulator
12/14/2006	WO2006132809A2 Monoclonal antibody reagents
12/14/2006	WO2006132607A1 Mutant allergen(s)
12/14/2006	WO2006132445A2 A pharmaceutical composition for treating and diagnosing a disorder associated with peroxisomal biogenesis and function
12/14/2006	WO2006132341A1 sc(Fv)2 SITE-DIRECTED MUTANT
12/14/2006	WO2006131953A2 Antibodies directed against the myelin basic protein recognising an epitope of cd64 and their use as immunosuppressants
12/14/2006	WO2006131952A1 Novel analgesic treatment with prolonged effect
12/14/2006	WO2006131951A2 MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT
12/14/2006	WO2006131752A1 Live and subunit vaccines
12/14/2006	WO2006131512A2 Anti-thrombotic agents
12/14/2006	WO2006131389A1 Receptor in dendritic cells
12/14/2006	WO2006131013A2 STABLE AND SOLUBLE ANTIBODIES INHIBITING TNFα
12/14/2006	WO2006111776A3 Pharmaceutical composition comprising serum obtained from a naive mammal
12/14/2006	WO2006109071A3 Vaccine against burkholderia infections
12/14/2006	WO2006104978A3 Antibodies against the tenascin major antigens
12/14/2006	WO2006100257A3 Vaccine and antibodies against parasitic nematodes
12/14/2006	WO2006089422A8 Protein and its use in diagnosing alzheimer's disease
12/14/2006	WO2006085961A3 Anti-mcp-1 antibodies, compositions, methods and uses
12/14/2006	WO2005095461A3 Gold-binding protein and use thereof
12/14/2006	WO2005003764A3 Assay for detecting atrial and brain natriuretic peptide prohormones
12/14/2006	US20060282920 Production of antibodies in transgenic plastids
12/14/2006	US20060282908 Identification of the genetic determinants of the polymorphic CYP3A5 expression
12/14/2006	US20060281902 Human signal peptide-containing proteins
12/14/2006	US20060281900 Lepidoptera voltage-gated calcium channels
12/14/2006	US20060281697 Methods and kits for diagnosing and treating b-cell chronic lymphocytic leukemia
12/14/2006	US20060281679 Human FGF-23 gene and gene expression products
12/14/2006	US20060281149 Transforming growth factor-beta-related molecules and uses thereof
12/14/2006	US20060281146 Novel compositions and methods for the treatment of immune related diseases

1 ... 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 ... 1494